Chew Elaine Gy, Liu Zhehao, Li Zheng, Chung Sun Ju, Lian Michelle M, Tandiono Moses, Heng Yue Jing, Ng Ebonne Y, Tan Louis Cs, Chng Wee Ling, Tan Tiak Ju, Peh Esther Kl, Ho Ying Swan, Chen Xiao Yin, Lim Erin Yt, Chang Chu Hua, Leong Jonavan J, Peh Ting Xuan, Chan Ling Ling, Chao Yinxia, Au Wing-Lok, Prakash Kumar M, Lim Jia Lun, Tay Yi Wen, Mok Vincent, Chan Anne Yy, Lin Juei-Jueng, Jeon Beom S, Song Kyuyoung, Tham Clement C, Pang Chi Pui, Ahn Jeeyun, Park Kyu Hyung, Wiggs Janey L, Aung Tin, Tan Ai Huey, Ahmad Annuar Azlina, Makarious Mary B, Blauwendraat Cornelis, Nalls Mike A, Robak Laurie A, Alcalay Roy N, Gan-Or Ziv, Reynolds Richard, Lim Shen-Yang, Xia Yun, Khor Chiea Chuen, Tan Eng-King, Wang Zhenxun, Foo Jia Nee
Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
Duke-National University of Singapore Medical School, Singapore, Singapore.
Nat Aging. 2025 Feb;5(2):205-218. doi: 10.1038/s43587-024-00760-7. Epub 2024 Nov 21.
Parkinson's disease (PD) is an incurable, progressive and common movement disorder that is increasing in incidence globally because of population aging. We hypothesized that the landscape of rare, protein-altering variants could provide further insights into disease pathogenesis. Here we performed whole-exome sequencing followed by gene-based tests on 4,298 PD cases and 5,512 controls of Asian ancestry. We showed that GBA1 and SMPD1 were significantly associated with PD risk, with replication in a further 5,585 PD cases and 5,642 controls. We further refined variant classification using in vitro assays and showed that SMPD1 variants with reduced enzymatic activity display the strongest association (<44% activity, odds ratio (OR) = 2.24, P = 1.25 × 10) with PD risk. Moreover, 80.5% of SMPD1 carriers harbored the Asian-specific p.Pro332Arg variant (OR = 2.16; P = 4.47 × 10). Our findings highlight the utility of performing exome sequencing in diverse ancestry groups to identify rare protein-altering variants in genes previously unassociated with disease.
帕金森病(PD)是一种无法治愈、进行性发展且常见的运动障碍疾病,由于人口老龄化,其在全球的发病率正在上升。我们推测,罕见的、导致蛋白质改变的变异情况可能为疾病发病机制提供进一步的见解。在此,我们对4298例亚洲血统的帕金森病患者和5512例对照进行了全外显子组测序,随后进行了基于基因的检测。我们发现,GBA1和SMPD1与帕金森病风险显著相关,并在另外5585例帕金森病患者和5642例对照中得到了验证。我们进一步通过体外试验优化了变异分类,并表明酶活性降低的SMPD1变异与帕金森病风险的关联最为强烈(活性<44%,比值比(OR)=2.24,P=1.25×10)。此外,80.5%的SMPD1携带者携带亚洲特异性的p.Pro332Arg变异(OR=2.16;P=4.47×10)。我们的研究结果凸显了在不同血统群体中进行外显子组测序以识别先前与疾病无关的基因中罕见的导致蛋白质改变的变异的作用。